VEGF/VEGFR-2 Upregulates EZH2 Expression in Lung Adenocarcinoma Cells and EZH2 Depletion Enhances the Response to Platinum-Based and VEGFR-2–Targeted Therapy
暂无分享,去创建一个
Milind B. Suraokar | K. Coombes | Jing Wang | J. Minna | I. Wistuba | L. Girard | C. Behrens | M. Suraokar | G. Simon | Heather Y. Lin | E. Riquelme | M. Nilsson | J. Heymach | J. Lee | W. Hong